Source:http://linkedlifedata.com/resource/pubmed/id/18429610
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
10
|
pubmed:dateCreated |
2008-5-16
|
pubmed:abstractText |
Analogues of the previously reported potent cytotoxic spiro[(dihydropyrazine-2,5-dione)-6,3'-(2',3'-dihydrothieno[2,3-b]naphtho-4',9'-dione)] derivatives (3, 3') were prepared to explore new structural requirements at the diketopiperazine domain for the cytotoxic activity. The in vitro activity was evaluated against the MCF-7 human breast carcinoma and SW 620 human colon carcinoma cell lines. The 4-[(2-N, N-dimethyl)amino]ethyl (6i), and the 4-(2-pyrrolydin)ethyl (6l) derivatives emerged as the most potent compounds of this series, with a cytotoxic activity comparable to that of doxorubicin. These compounds, in both racemic and pure enantiomeric forms, showed also a high efficacy in cell lines resistant to doxorubicin (MCF-7/Dx) and in cell lines that were highly resistant to treatment with doxorubicin, such as HEK-293 (kidney), M-14 (melanoma), and HeLa (cervical adenocarcinoma) human cell lines. In addition, the effects on growth and cell cycle progression in CaCo-2 cell line (colon adenocarcinoma) and DNA-binding properties were investigated.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/DNA,
http://linkedlifedata.com/resource/pubmed/chemical/Diketopiperazines,
http://linkedlifedata.com/resource/pubmed/chemical/Naphthoquinones,
http://linkedlifedata.com/resource/pubmed/chemical/Pyrazines
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0022-2623
|
pubmed:author |
pubmed-author:AquinoClaudioC,
pubmed-author:BertaminoAlessiaA,
pubmed-author:CampigliaPietroP,
pubmed-author:CarotenutoAlfonsoA,
pubmed-author:Gomez-MonterreyIsabelI,
pubmed-author:GriecoPaoloP,
pubmed-author:IanelliPioP,
pubmed-author:MorelloSilvanaS,
pubmed-author:NovellinoEttoreE,
pubmed-author:PintoAldoA,
pubmed-author:SalaMarinaM,
pubmed-author:StiusoPaolaP
|
pubmed:issnType |
Print
|
pubmed:day |
22
|
pubmed:volume |
51
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2924-32
|
pubmed:meshHeading |
pubmed-meshheading:18429610-Antineoplastic Agents,
pubmed-meshheading:18429610-Cell Cycle,
pubmed-meshheading:18429610-Cell Line, Tumor,
pubmed-meshheading:18429610-DNA,
pubmed-meshheading:18429610-Diketopiperazines,
pubmed-meshheading:18429610-Drug Screening Assays, Antitumor,
pubmed-meshheading:18429610-Humans,
pubmed-meshheading:18429610-Magnetic Resonance Spectroscopy,
pubmed-meshheading:18429610-Models, Molecular,
pubmed-meshheading:18429610-Naphthoquinones,
pubmed-meshheading:18429610-Pyrazines,
pubmed-meshheading:18429610-Structure-Activity Relationship
|
pubmed:year |
2008
|
pubmed:articleTitle |
Spiro[(dihydropyrazin-2,5-dione)-6,3'-(2',3'-dihydrothieno[2,3-b]naphtho-4',9'-dione)]-based cytotoxic agents: structure-activity relationship studies on the substituent at N4-position of the diketopiperazine domain.
|
pubmed:affiliation |
Dipartimento di Chimica Farmaceutica e Tossicologica, University of Naples Federico II, 80131 Napoli, Italy.
|
pubmed:publicationType |
Journal Article
|